Kinase Inhibitors in Genetic Diseases

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• Kinase-regulated signaling pathways are implicated in rare genetic disease development.
• Understanding these mechanisms offers potential for targeted therapies.
• Kinase inhibitors, some used in cancer treatment, are being explored for genetic disorders.

Purpose of the Study:

• To review the therapeutic potential of kinase inhibitors for rare genetic diseases.
• To describe the signaling pathways involved in tuberous sclerosis, RASopathies, and ciliopathies.
• To identify current and potential kinase targets for these conditions.

Main Methods:

• Literature review of studies on kinase inhibitors and rare genetic diseases.
• Analysis of signaling pathways implicated in tuberous sclerosis, RASopathies, and ciliopathies.
• Identification and summary of known and emerging kinase targets.

Main Results:

• Kinase inhibitors represent a viable therapeutic strategy for specific genetic pathologies.
• Several signaling pathways are crucial in the pathogenesis of reviewed diseases.
• Specific kinase targets have been identified and are under investigation.

Conclusions:

• Kinase inhibitors offer a promising avenue for targeted treatment of rare genetic diseases.
• Further research into identified kinase targets could lead to novel therapeutic approaches.
• Repurposing existing kinase inhibitors may accelerate treatment development for these conditions.